What is the ticker symbol for RayzeBio?

RayzeBio trades under the ticker RYZB on NASDAQ.

What sector does RayzeBio operate in?

RayzeBio is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze RYZB in a portfolio?

PortView shows RYZB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

RayzeBio (RYZB) Stock Analysis

NASDAQHealthcareBiotechnology

$62.49+0.02%

1-year price historyRange $18.42 – $62.49

52-week range$62.49

$17.95$62.51

What RayzeBio does

RayzeBio, Inc. is dedicated to creating radiopharmaceutical therapies (RPTs) for oncology applications. Its primary therapeutic candidate, RYZ101, is currently advancing through Phase 3 clinical trials for the management of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The company's innovative pipeline also features RYZ801, a distinct peptide engineered to deliver Actinium-225 (Ac225) by targeting GPC3, intended for treating hepatocellular carcinoma (HCC). Additionally, RayzeBio is developing RYZ811, a companion diagnostic imaging agent comprising a peptide binder, a chelator, and Gallium-68 (Ga68). Another active development program involves a novel proprietary small molecule designed to target CA9, delivering Ac225 for potential use against clear cell renal cell carcinoma (ccRCC). The firm was established in 2020 and is headquartered in San Diego, California.

Key metrics

Market cap

$3.75B

P/E (TTM)

-57.86

EPS (TTM)

$-1.08

Beta

3.79

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$55.78

200-day avg

$36.72

52-week high

$62.51

52-week low

$17.95

CEO

Kenneth Song

ETFs linked to RYZB

Broad-market and Healthcare sector ETFs an investor holding RayzeBio is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how RYZB fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze RYZB in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for RayzeBio?: RayzeBio trades under the ticker RYZB on NASDAQ.
Which exchange is RYZB listed on?: RYZB is listed on NASDAQ.
What sector does RayzeBio operate in?: RayzeBio is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze RYZB in a portfolio?: PortView shows RYZB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.